EU secures deal with Pfizer/BioNTech for up to 1.8bn extra vaccine doses

The approved contract is said to allow the EU to move to the next stage of response to the Covid-19 pandemic, giving booster shots, dealing with possible escape variants and allowing for rollouts of the vaccine to teenagers and children.